Publications by authors named "Nicolas Montpas"

Claim this Profile
L
Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging.
Nicolas Montpas, Geneviève St-Onge, Nassr Nama, David Rhainds, Besma Benredjem

J Biol Chem· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.
Joshua J Ziarek, Andrew B Kleist, Nir London, Barak Raveh, Nicolas Montpas

Sci Signal· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of novel CXC chemokine receptor 7 (CXCR7) ligands: selectivity switch from CXCR4 antagonists with a cyclic pentapeptide scaffold.
Shinya Oishi, Tomoko Kuroyanagi, Tatsuhiko Kubo, Nicolas Montpas, Yasushi Yoshikawa

J Med Chem· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mode of binding of the cyclic agonist peptide TC14012 to CXCR7: identification of receptor and compound determinants.
Nicolas Montpas, Jérôme Cabana, Geneviève St-Onge, Stéphanie Gravel, Geneviève Morin

Biochemistry· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of currently marketed heparin products: adverse event relevant bioassays.
Cynthia D Sommers, Nicolas Montpas, Albert Adam, David A Keire

J Pharm Biomed Anal· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro.
Albert Adam, Nicolas Montpas, David Keire, Anik Désormeaux, Nancy J Brown

Biomaterials· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered cardiac bradykinin metabolism in experimental diabetes caused by the variations of angiotensin-converting enzyme and other peptidases.
Albert Adam, Patrick Leclair, Nicolas Montpas, Gérémy Abdull Koumbadinga, Hélène Bachelard

Neuropeptides· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis